Tom Powles

Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments

Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:

“The ESMO guidlines make a clear distinction between papillary and other ‘non-clear cell’ renal cancers. Mixing these together has hampered new treatments. Sarcomatoid needs upfront PD1 combos. Other subgroups (chromaphobe etc) need more data.”

Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments

Further information.
Source: Tom Powles/X

cancer ESMO non-clear cell renal cancers OncoDaily Oncology Sarcomatoid Tom Powles